• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

GI Dynamics

GI Dynamics EndoBarrier meets endpoints in diabetes, obesity study

June 15, 2022 By Sean Whooley

GI Dynamics today announced the results of a study of its EndoBarrier system that met efficacy and safety endpoints. Boston-based GI Dynamics designed its EndoBarrier endoscopically delivered device therapy as a non-surgical, alternative treatment for type 2 diabetes and obesity for patients who do not have adequate control of their conditions through their current medication […]

Filed Under: Clinical Trials, Diabetes, Endoscopic Tagged With: GI Dynamics

GI Dynamics names new CEO

November 9, 2020 By Sean Whooley

GI Dynamics (ASX:GID) announced that CEO & president Scott Schorer has departed and that Joseph Virgilio is assuming both roles. Virgilio, previously the company’s COO, took over as president & CEO on Nov. 2, with no changes made to his current compensation as of yet. GI Dynamics confirmed in a news release that Virgilio’s current executive […]

Filed Under: Business/Financial News, Diabetes, Weight loss Tagged With: GI Dynamics, Personnel Moves

GI Dynamics announces $10m in financing

August 23, 2019 By Sean Whooley

GI Dynamics (ASX:GID) announced yesterday that it agreed to terms of a financing of up to approximately $10 million with Crystal Amber (GBX:CRS) to continue developing its EndoBarrier device. EndoBarrier is a plastic sleeve designed treat Type 2 diabetes and obesity by preventing the absorption of nutrients from food as it exits the stomach and […]

Filed Under: Diabetes, Funding Roundup, Weight loss Tagged With: Crystal Amber, GI Dynamics

GI Dynamics considers delisting from Australian exchange

June 4, 2019 By Fink Densford

GI Dynamics (ASX:GID) is considering delisting itself from the official list of the Australian Securities Exchange, according to a recently posted SEC filing. The option came as a proposal from the Lexington, Mass.-based company’s board of directors, set to be voted on at an upcoming stockholder meeting. GI Dynamics said that the consideration comes due to […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: GI Dynamics

GI Dynamics eyes CE Mark in 2020, reaps $2m in warrants exercise

May 4, 2019 By Brad Perriello

GI Dynamics (ASX:GID) said it launched a pivotal trial of its EndoBarrier plastic gut sleeve, aiming to win back CE Mark approval next year, and raised the second tranche of a $10 million financing plan. The Boston-based company won approval for the trial in February to observe the EndoBarrier sleeve designed to prevent the absorption of […]

Filed Under: Clinical Trials, Diabetes, Regulatory/Compliance, Weight loss Tagged With: Crystal Amber, GI Dynamics

GI Dynamics wins IRB approval for pivotal U.S. EndoBarrier trial

February 14, 2019 By Fink Densford

GI Dynamics (ASX:GID) said yesterday it won Institutional Review Board approval to launch a pivotal trial of its EndoBarrier device exploring its ability to treat diabetes and obesity. The EndoBarrier device is a plastic gut sleeve designed to prevent the absorption of nutrients from food as it exits the stomach and enters the intestinal tract to treat type […]

Filed Under: Clinical Trials, Diabetes, Featured, Weight loss Tagged With: GI Dynamics

Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves – January 8, 2019

January 8, 2019 By Fink Densford

Insulet (NSDQ:PODD) said yesterday that it tapped former Medtronic minimally invasive therapies CFO and finance VP Wayde McMillan as its new chief financial officer, replacing Michael Levitz. The Acton, Mass.-based diabetes-focused medtech company said that McMillan will join the company in February and that Levitz will continue as an advisor for a period following the […]

Filed Under: Business/Financial News, Featured Tagged With: AxoGen, Bonesupport, Cerus Corp., GI Dynamics, Insulet, Livongo, Medidata Solutions, Medtronic, pressaomedical, quantadialysistech, Reva Medical Inc., Senseonics, Smith & Nephew, taelifesciences, wrightmedical

Gerresheimer taps Metzner as CFO | Personnel Moves – December 14, 2018

December 14, 2018 By Fink Densford

Gerresheimer said late last month that it tapped Dr. Bernd Metzner as its new chief financial officer, set to take position at the latest by July 1 next year. Prior to joining the Dusseldorf-based company, Metzner acted as CFO at Ströer, a position he took up in June 2014. He also held positions at Bayer […]

Filed Under: Business/Financial News Tagged With: Aethlon Medical Inc., Amazon, Bayer, Berkshire Hathaway, berkshiresterilemanufacturing, Common Sensing, Frazier Healthcare Ventures, gerresheimer, GI Dynamics, JP Morgan Chase, oculartherapeutix, Organovo, Personnel Moves

GI Dynamics inks deal to launch Indian EndoBarrier trial

November 28, 2018 By Fink Densford

GI Dynamics (ASX:GID) said today it inked a deal with Apollo Sugar, a collaboration between Apollo Health & Lifestyle Limited and Sanofi, to jointly launch a safety and efficacy study of the EndoBarrier system in India. Through the deal, the groups will launch a clinical trial that aims to collect data from 100 randomized patients, with […]

Filed Under: Clinical Trials, Featured, Weight loss Tagged With: GI Dynamics

GI Dynamics raises $3m

November 19, 2018 By Fink Densford

GI Dynamics (ASX:GID) said late last week that it closed the second tranche of a private placement, bringing in a total of $2.8 million through the issuance of CHESS Depository Interests. The company said that through the second tranche, it issued approximately 197.2 million CDIs, which represent 3.9 million shares of common stock, to “sophisticated and professional […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: GI Dynamics

GI Dynamics eyes 2019 EU market return for EndoBarrier

October 5, 2018 By Brad Perriello

GI Dynamics (ASX:GID) said yesterday that it tapped a new notified body in Europe, nearly a year after losing CE Mark approval there, as it eyes a market return for its EndoBarrier device by the end of next year. In the European Union, notified bodies are used as part of the regulatory system to assess product […]

Filed Under: Diabetes, Featured, Regulatory/Compliance, Weight loss Tagged With: GI Dynamics

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 15
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS